Publicacións nas que colabora con Antonio Gil Moreno (64)

2023

  1. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

2022

  1. Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

  2. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

2021

  1. M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

    Gynecologic Oncology, Vol. 161, Núm. 3, pp. 681-686

  2. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas

    Biomedicine and Pharmacotherapy, Vol. 140

2020

  1. Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 127, Núm. 1, pp. 99-105

  2. Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  3. Intraoperative Human Papillomavirus Test Predicts 24-Month High-Grade Squamous Intraepithelial Lesion Recurrence Saving Costs: A Prospective Cohort Study

    Journal of Lower Genital Tract Disease, Vol. 24, Núm. 4, pp. 367-371

2019

  1. A novel saliva-based mirna signature for colorectal cancer diagnosis

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  2. Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study

    Human Pathology, Vol. 89, pp. 90-98

  3. Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer

    Cancers, Vol. 11, Núm. 12

  4. Nerve-sparing versus non-nerve-sparing radical hysterectomy: Surgical and long-term oncological outcomes

    Oncotarget, Vol. 10, Núm. 44, pp. 4598-4608

  5. Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer

    Journal of Proteome Research, Vol. 18, Núm. 3, pp. 1043-1053

2018

  1. ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer

    Oncotarget, Vol. 9, Núm. 24, pp. 16648-16664

  2. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study

    International Journal of Gynecological Cancer, Vol. 28, Núm. 3, pp. 514-523

  3. Human salivary microRNAs in Cancer

    Journal of Cancer, Vol. 9, Núm. 4, pp. 638-649

  4. Patient-derived xenograft models for endometrial cancer research

    International Journal of Molecular Sciences, Vol. 19, Núm. 8

2017

  1. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer

    Journal of Pathology, Vol. 241, Núm. 4, pp. 475-487

  2. Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

    Modern Pathology, Vol. 30, Núm. 1, pp. 134-145

  3. Metabolomic and Lipidomic Profiling Identifies the Role of the RNA Editing Pathway in Endometrial Carcinogenesis

    Scientific Reports, Vol. 7, Núm. 1